# Non-Acute Pain

Aggregated by Superinsight from public-domain sources, as of 2026-10-05. Domain: wc/ny.

---

## Non-Acute Pain MTG § A.1 — Medical Care {#a.1}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.1*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=7>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.1 — Medical Care** · page 7 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.2 — Rendering Of Medical Services {#a.2}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.2*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=7>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.2 — Rendering Of Medical Services** · page 7 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.3 — Positive Patient Response {#a.3}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.3*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=7>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.3 — Positive Patient Response** · page 7 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.4 — Re-Evaluate Treatment {#a.4}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.4*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=7>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.4 — Re-Evaluate Treatment** · page 7 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.5 — Education {#a.5}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.5*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=7>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.5 — Education** · pages 7–8 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.6 — Acuity {#a.6}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.6*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=8>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.6 — Acuity** · page 8 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.7 — Initial Evaluation {#a.7}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.7*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=8>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.7 — Initial Evaluation** · page 8 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.8 — Diagnostic Time Frames {#a.8}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.8*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=8>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.8 — Diagnostic Time Frames** · page 8 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.9 — Treatment Time Frames {#a.9}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.9*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=8>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.9 — Treatment Time Frames** · page 8 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.10 — Delayed Recovery {#a.10}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.10*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=8>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.10 — Delayed Recovery** · page 8 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.11 — Active Interventions {#a.11}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.11*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=8>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.11 — Active Interventions** · pages 8–9 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.12 — Active Therapeutic Exercise Program {#a.12}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.12*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=9>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.12 — Active Therapeutic Exercise Program** · page 9 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.13 — Diagnostic Imaging And Testing Procedures {#a.13}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.13*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=9>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.13 — Diagnostic Imaging And Testing Procedures** · page 9 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.14 — Surgical Interventions {#a.14}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.14*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=9>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.14 — Surgical Interventions** · pages 9–10 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.15 — Pre-Authorization {#a.15}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.15*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=10>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.15 — Pre-Authorization** · page 10 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.16 — Psychological/Psychiatric Evaluations {#a.16}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.16*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=10>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.16 — Psychological/Psychiatric Evaluations** · page 10 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.17 — Personality/Psychological/Psychosocial Intervention {#a.17}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.17*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=10>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.17 — Personality/Psychological/Psychosocial Intervention** · pages 10–11 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.18 — Functional Capacity Evaluation (FCE) {#a.18}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.18*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=11>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.18 — Functional Capacity Evaluation (FCE)** · page 11 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.19 — Return To Work {#a.19}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.19*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=12>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.19 — Return To Work** · page 12 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.20 — Job Site Evaluation {#a.20}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.20*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=12>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.20 — Job Site Evaluation** · page 12 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.21 — Guideline Recommendations And Medical Evidence {#a.21}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.21*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=12>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.21 — Guideline Recommendations And Medical Evidence** · page 12 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.22 — Experimental/Investigational Treatment {#a.22}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.22*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=12>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.22 — Experimental/Investigational Treatment** · page 12 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.23 — Injured Workers As Patients {#a.23}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.23*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=13>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.23 — Injured Workers As Patients** · page 13 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § A.24 — Scope Of Practice {#a.24}

*NY WCB Non-Acute Pain MTG, 2d ed., § A.24*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=13>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ A.24 — Scope Of Practice** · pages 13–14 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § C.1.a — Biomedical vs. Biopsychosocial Approaches to the Diagnosis, Treatment and Management of Pain {#c.1.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § C.1.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=14>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ C.1.a — Biomedical vs. Biopsychosocial Approaches to the Diagnosis, Treatment and Management of Pain** · pages 14–15 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § C.1.b — Medical versus Self-Management Model {#c.1.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § C.1.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=16>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ C.1.b — Medical versus Self-Management Model** · page 16 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § C.1.c — Delayed Recovery {#c.1.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § C.1.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=16>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ C.1.c — Delayed Recovery** · pages 16–17 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § C.1.d — Importance of Early Intervention {#c.1.d}

*NY WCB Non-Acute Pain MTG, 2d ed., § C.1.d*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=17>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ C.1.d — Importance of Early Intervention** · page 17 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § C.1.e — Functional Restoration Approach to Non-Acute Pain Management {#c.1.e}

*NY WCB Non-Acute Pain MTG, 2d ed., § C.1.e*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=17>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ C.1.e — Functional Restoration Approach to Non-Acute Pain Management** · page 17 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § C.1.f — Pain Outcomes and Endpoints {#c.1.f}

*NY WCB Non-Acute Pain MTG, 2d ed., § C.1.f*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=17>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ C.1.f — Pain Outcomes and Endpoints** · pages 17–18 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § C.1.g — Summary {#c.1.g}

*NY WCB Non-Acute Pain MTG, 2d ed., § C.1.g*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=18>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ C.1.g — Summary** · page 18 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1 — History Taking and Physical Examination {#d.1}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=19>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1 — History Taking and Physical Examination** · page 19 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a — Pain History, History of Present Illness {#d.1.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=19>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a — Pain History, History of Present Illness** · page 19 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.i — Site of Pain: Localization and distribution of the pain help determine the type of pain the patient has (i.e., central versus peripheral). Use of a pain {#d.1.a.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=19>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.i — Site of Pain: Localization and distribution of the pain help determine the type of pain the patient has (i.e., central versus peripheral). Use of a pain** · page 19 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.ii — Onset: Circumstances during which the pain began (e.g., an accident, an illness, a stressful incident or spontaneous onset). {#d.1.a.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=19>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.ii — Onset: Circumstances during which the pain began (e.g., an accident, an illness, a stressful incident or spontaneous onset).** · page 19 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.iv — Pain Characteristics: Such as burning, shooting, stabbing, or aching. Time {#d.1.a.iv}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.iv*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=19>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.iv — Pain Characteristics: Such as burning, shooting, stabbing, or aching. Time** · page 19 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.ix — Functional Limitations: What are the specific functional activities/ADLs that {#d.1.a.ix}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.ix*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=19>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.ix — Functional Limitations: What are the specific functional activities/ADLs that** · page 19 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.vi — List of activities: Such as gait, weight bearing, or resistance, which {#d.1.a.vi}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.vi*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=19>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.vi — List of activities: Such as gait, weight bearing, or resistance, which** · page 19 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.vii — Associated Symptoms: Does the patient have numbness or paresthesia, {#d.1.a.vii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.vii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=19>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.vii — Associated Symptoms: Does the patient have numbness or paresthesia,** · page 19 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.x — Fear Avoidance: Does the patient report being afraid to move or engage in daily activities of living because of fear of further hurting self? (See {#d.1.a.x}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.x*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=20>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.x — Fear Avoidance: Does the patient report being afraid to move or engage in daily activities of living because of fear of further hurting self? (See** · page 20 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.xi — Diagnostic Tests: All previous radiological and laboratory investigations {#d.1.a.xi}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.xi*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=20>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.xi — Diagnostic Tests: All previous radiological and laboratory investigations** · page 20 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.xii — Prior Treatment: Chronological review of medical records including {#d.1.a.xii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.xii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=20>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.xii — Prior Treatment: Chronological review of medical records including** · page 20 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.xiv — Medications: History of and current use of medications, including over the counter and herbal/dietary supplements, to determine drug usage (or {#d.1.a.xiv}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.xiv*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=20>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.xiv — Medications: History of and current use of medications, including over the counter and herbal/dietary supplements, to determine drug usage (or** · page 20 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.xvi — Other confounding psychosocial issues should be explored, including the presence of psychosocial, psychiatric, or social factors. {#d.1.a.xvi}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.xvi*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=20>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.xvi — Other confounding psychosocial issues should be explored, including the presence of psychosocial, psychiatric, or social factors.** · page 20 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.a.xvii — Treatment Expectations: What does the patient believe is causing his/her {#d.1.a.xvii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.a.xvii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=20>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.a.xvii — Treatment Expectations: What does the patient believe is causing his/her** · page 20 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.b — Past Medical History {#d.1.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=20>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.b — Past Medical History** · page 20 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.b.i — Level of education and language barriers: The level of education and language barriers may influence ability to understand instructions, {#d.1.b.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.b.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=20>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.b.i — Level of education and language barriers: The level of education and language barriers may influence ability to understand instructions,** · page 20 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.b.ii — Work History/Occupation: To include both impact of injury on job duties {#d.1.b.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.b.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=20>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.b.ii — Work History/Occupation: To include both impact of injury on job duties** · page 20 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.b.v — Family Environment: Does the patient live with family or friends? {#d.1.b.v}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.b.v*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=21>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.b.v — Family Environment: Does the patient live with family or friends?** · page 21 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.b.vi — Cultural Considerations: For example, ethnicity of the patient, including {#d.1.b.vi}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.b.vi*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=21>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.b.vi — Cultural Considerations: For example, ethnicity of the patient, including** · page 21 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.b.vii — Pre-existing Conditions: Treatment of the condition(s) is appropriate when {#d.1.b.vii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.b.vii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=21>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.b.vii — Pre-existing Conditions: Treatment of the condition(s) is appropriate when** · page 21 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.b.viii — Psychosocial History and History of Substance Abuse: Has the patient {#d.1.b.viii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.b.viii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=21>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.b.viii — Psychosocial History and History of Substance Abuse: Has the patient** · page 21 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.c — Physical Examination {#d.1.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=21>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.c — Physical Examination** · page 21 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.c.ii — Accepted pain assessment tool (e.g., Visual Analog Scale [VAS] or Numerical Rating Scale [NRS]). {#d.1.c.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.c.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=22>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.c.ii — Accepted pain assessment tool (e.g., Visual Analog Scale [VAS] or Numerical Rating Scale [NRS]).** · page 22 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.c.iv — General physical examination, as indicated: Including chest, abdominal, {#d.1.c.iv}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.c.iv*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=22>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.c.iv — General physical examination, as indicated: Including chest, abdominal,** · page 22 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.c.ix.a — If applicable, Waddell Signs, which include 5 categories of clinical signs (1) tenderness: superficial and non-anatomic, (2) {#d.1.c.ix.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.c.ix.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=22>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.c.ix.a — If applicable, Waddell Signs, which include 5 categories of clinical signs (1) tenderness: superficial and non-anatomic, (2)** · pages 22–23 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.c.ix.b — Variability on formal exam including variable sensory exam, {#d.1.c.ix.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.c.ix.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=23>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.c.ix.b — Variability on formal exam including variable sensory exam,** · page 23 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.c.ix.c — Inconsistencies between formal exam and observed abilities {#d.1.c.ix.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.c.ix.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=23>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.c.ix.c — Inconsistencies between formal exam and observed abilities** · page 23 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.c.v — Neurologic Evaluation: Includes examination of cranial nerves, muscle {#d.1.c.v}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.c.v*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=22>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.c.v — Neurologic Evaluation: Includes examination of cranial nerves, muscle** · page 22 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.c.vi — Sensory Evaluation: Routine quantitative sensory testing, such as {#d.1.c.vi}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.c.vi*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=22>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.c.vi — Sensory Evaluation: Routine quantitative sensory testing, such as** · page 22 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.c.vii — Musculoskeletal Evaluation: Includes range-of-motion, segmental mobility, {#d.1.c.vii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.c.vii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=22>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.c.vii — Musculoskeletal Evaluation: Includes range-of-motion, segmental mobility,** · page 22 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.c.viii — Electrodiagnostic Studies (EDX) (i.e., EMG/NCV): Are separate diagnostic {#d.1.c.viii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.c.viii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=22>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.c.viii — Electrodiagnostic Studies (EDX) (i.e., EMG/NCV): Are separate diagnostic** · page 22 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.1.d — Red Flags {#d.1.d}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.1.d*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=23>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.1.d — Red Flags** · page 23 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.2 — Personality / Psychological / Psychosocial Clinical Evaluation for Pain Management {#d.2}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.2*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=23>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.2 — Personality / Psychological / Psychosocial Clinical Evaluation for Pain Management** · page 23 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.2.a — Clinical Evaluation {#d.2.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.2.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=23>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.2.a — Clinical Evaluation** · page 23 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.2.a.i — History of Injury. The history of the injury should be reported in the patient’s words or using similar terminology. Caution must be exercised {#d.2.a.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.2.a.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=23>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.2.a.i — History of Injury. The history of the injury should be reported in the patient’s words or using similar terminology. Caution must be exercised** · pages 23–25 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.2.a.ix — Treatment recommendations: With respect to specific goals, frequency, {#d.2.a.ix}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.2.a.ix*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=25>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.2.a.ix — Treatment recommendations: With respect to specific goals, frequency,** · page 25 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.2.a.viii — Pre-existing psychiatric conditions: Treatment of these conditions is {#d.2.a.viii}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.2.a.viii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=25>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.2.a.viii — Pre-existing psychiatric conditions: Treatment of these conditions is** · page 25 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.2.b — Tests of Psychological Functioning {#d.2.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.2.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=25>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.2.b — Tests of Psychological Functioning** · page 25 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § D.3 — Diagnostic Studies (Imaging, Electrodiagnostic Studies (EDX), Special Studies, Laboratory Testing) {#d.3}

*NY WCB Non-Acute Pain MTG, 2d ed., § D.3*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=25>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ D.3 — Diagnostic Studies (Imaging, Electrodiagnostic Studies (EDX), Special Studies, Laboratory Testing)** · page 25 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.1 — Delayed Recovery {#e.1}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.1*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=25>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.1 — Delayed Recovery** · pages 25–26 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.2.a — Evaluation {#e.2.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.2.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=26>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.2.a — Evaluation** · pages 26–27 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.2.b — Intervention {#e.2.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.2.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=27>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.2.b — Intervention** · page 27 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.3 — Non-Pharmacological Treatment Options {#e.3}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.3*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=27>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.3 — Non-Pharmacological Treatment Options** · pages 27–28 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.4 — Non-Acute Pain Management Programs (Interdisciplinary or Functional Restoration Pain Management Program) {#e.4}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.4*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=28>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.4 — Non-Acute Pain Management Programs (Interdisciplinary or Functional Restoration Pain Management Program)** · page 28 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.4.a — Interdisciplinary or functional restoration program {#e.4.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.4.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=28>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.4.a — Interdisciplinary or functional restoration program** · page 28 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.4.b — Core components of an interdisciplinary pain program {#e.4.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.4.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=28>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.4.b — Core components of an interdisciplinary pain program** · pages 28–29 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.5 — Multidisciplinary Programs {#e.5}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.5*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=29>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.5 — Multidisciplinary Programs** · page 29 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.6 — Goals of Pain Management Programs {#e.6}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.6*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=29>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.6 — Goals of Pain Management Programs** · pages 29–30 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.7 — Types of Programs {#e.7}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.7*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=30>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.7 — Types of Programs** · page 30 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.8.a — Inpatient or Outpatient Pain Management Programs {#e.8.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.8.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=30>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.8.a — Inpatient or Outpatient Pain Management Programs** · page 30 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.8.b — Cognitive Behavioral Therapy {#e.8.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.8.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=30>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.8.b — Cognitive Behavioral Therapy** · page 30 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.8.c — Psychological Evaluations {#e.8.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.8.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=30>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.8.c — Psychological Evaluations** · page 30 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.8.d — Psychological Intervention {#e.8.d}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.8.d*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=30>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.8.d — Psychological Intervention** · pages 30–31 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § E.8.e — Biofeedback {#e.8.e}

*NY WCB Non-Acute Pain MTG, 2d ed., § E.8.e*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=31>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ E.8.e — Biofeedback** · page 31 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1 — Non-Opioid Medications and Medical Management {#f.1}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=32>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1 — Non-Opioid Medications and Medical Management** · page 32 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.a — Introduction {#f.1.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=32>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.a — Introduction** · page 32 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.b — Goals {#f.1.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=32>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.b — Goals** · page 32 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.c — Pharmacological Principles {#f.1.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=32>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.c — Pharmacological Principles** · pages 32–33 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.d — Neuropathic Pain {#f.1.d}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.d*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=33>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.d — Neuropathic Pain** · pages 33–34 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e — Medications {#f.1.e}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=34>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e — Medications** · page 34 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.i — Alpha-Acting Agents (e.g. clonidine) {#f.1.e.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=34>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.i — Alpha-Acting Agents (e.g. clonidine)** · page 34 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.ii — Anticonvulsants {#f.1.e.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=34>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.ii — Anticonvulsants** · page 34 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.ii.a — Carbamazepine {#f.1.e.ii.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.ii.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=34>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.ii.a — Carbamazepine** · page 34 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.ii.b — Gabapentin {#f.1.e.ii.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.ii.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=35>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.ii.b — Gabapentin** · page 35 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.ii.c — Pregabalin {#f.1.e.ii.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.ii.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=35>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.ii.c — Pregabalin** · page 35 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.ii.d — Topiramate {#f.1.e.ii.d}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.ii.d*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=35>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.ii.d — Topiramate** · page 35 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.ii.e — Lamotrigine {#f.1.e.ii.e}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.ii.e*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=36>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.ii.e — Lamotrigine** · page 36 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.iii — Antidepressants {#f.1.e.iii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.iii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=36>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.iii — Antidepressants** · page 36 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.iii.a — Tricyclic Antidepressants (TCAs) (e.g. amitriptyline, desipramine, nortriptyline, doxepin, imipramine, {#f.1.e.iii.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.iii.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=36>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.iii.a — Tricyclic Antidepressants (TCAs) (e.g. amitriptyline, desipramine, nortriptyline, doxepin, imipramine,** · pages 36–37 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.iii.b — Selective Serotonin Reuptake Inhibitors (SSRIs) {#f.1.e.iii.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.iii.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=37>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.iii.b — Selective Serotonin Reuptake Inhibitors (SSRIs)** · page 37 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.iii.c — Selective Serotonin Norepinephrine Reuptake {#f.1.e.iii.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.iii.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=37>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.iii.c — Selective Serotonin Norepinephrine Reuptake** · page 37 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.iii.d — Atypical Antidepressants/Other Agents (e.g., bupropion, mirtazapine, nefazodone) {#f.1.e.iii.d}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.iii.d*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=37>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.iii.d — Atypical Antidepressants/Other Agents (e.g., bupropion, mirtazapine, nefazodone)** · page 37 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.iii.e — Compound Medications {#f.1.e.iii.e}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.iii.e*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=37>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.iii.e — Compound Medications** · page 37 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.iii.f — Glucosamine/Chondroitin {#f.1.e.iii.f}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.iii.f*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=37>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.iii.f — Glucosamine/Chondroitin** · page 37 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.iii.g — Hypnotics and Sedatives {#f.1.e.iii.g}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.iii.g*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=37>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.iii.g — Hypnotics and Sedatives** · pages 37–38 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.iv — Non-Steroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Non-Acute Pain {#f.1.e.iv}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.iv*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=38>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.iv — Non-Steroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Non-Acute Pain** · page 38 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.ix — N-Methyl-D-Aspartic Acid Receptor Antagonists (e.g., ketamine) {#f.1.e.ix}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.ix*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=40>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.ix — N-Methyl-D-Aspartic Acid Receptor Antagonists (e.g., ketamine)** · page 40 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.v — NSAIDs for Patients at High Risk of Gastrointestinal Bleeding {#f.1.e.v}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.v*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=38>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.v — NSAIDs for Patients at High Risk of Gastrointestinal Bleeding** · pages 38–39 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.vi — NSAIDs for Patients at Risk for Cardiovascular Adverse Effects {#f.1.e.vi}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.vi*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=39>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.vi — NSAIDs for Patients at Risk for Cardiovascular Adverse Effects** · page 39 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.vii — Acetaminophen for Treatment of Non-Acute Pain {#f.1.e.vii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.vii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=39>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.vii — Acetaminophen for Treatment of Non-Acute Pain** · page 39 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.viii — Topical Medications {#f.1.e.viii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.viii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=40>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.viii — Topical Medications** · page 40 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.x — Selective Cyclo-oxygenase-2 (COX-2) Inhibitors {#f.1.e.x}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.x*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=40>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.x — Selective Cyclo-oxygenase-2 (COX-2) Inhibitors** · pages 40–41 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.1.e.xi — Skeletal Muscle Relaxants (e.g., baclofen, cyclobenzaprine, metaxalone, tizanidine) {#f.1.e.xi}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.1.e.xi*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=41>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.1.e.xi — Skeletal Muscle Relaxants (e.g., baclofen, cyclobenzaprine, metaxalone, tizanidine)** · page 41 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2 — Opioids: Initiating Transitioning and Managing Long-Term Oral {#f.2}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=41>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2 — Opioids: Initiating Transitioning and Managing Long-Term Oral** · page 41 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.a — Long-Term Use of Opioids in the Opioid-Naïve Patient: Opioid Therapeutic {#f.2.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=41>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.a — Long-Term Use of Opioids in the Opioid-Naïve Patient: Opioid Therapeutic** · page 41 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.a.i — Overview {#f.2.a.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.a.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=41>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.a.i — Overview** · pages 41–42 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.a.ii — Goals and Objectives of Opioid Trial {#f.2.a.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.a.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=42>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.a.ii — Goals and Objectives of Opioid Trial** · page 42 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.a.iii — Risk Assessment/Stratification {#f.2.a.iii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.a.iii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=42>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.a.iii — Risk Assessment/Stratification** · pages 42–43 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.a.iv — Therapeutic Trial Criteria (Opioid-Naïve Patient) {#f.2.a.iv}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.a.iv*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=43>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.a.iv — Therapeutic Trial Criteria (Opioid-Naïve Patient)** · pages 43–45 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.a.v — Therapeutic Trial {#f.2.a.v}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.a.v*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=45>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.a.v — Therapeutic Trial** · page 45 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.b — Long-Term Use of Opioids: Transitioning/Managing Patients on {#f.2.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=45>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.b — Long-Term Use of Opioids: Transitioning/Managing Patients on** · pages 45–46 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.b.i — Overview {#f.2.b.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.b.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=46>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.b.i — Overview** · page 46 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.b.ii — Approach {#f.2.b.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.b.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=46>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.b.ii — Approach** · pages 46–47 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.c.i — Overview {#f.2.c.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.c.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=47>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.c.i — Overview** · page 47 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.2.c.ii — Principles for Safe Management include: {#f.2.c.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.2.c.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=47>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.2.c.ii — Principles for Safe Management include:** · pages 47–50 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.a — Introduction {#f.3.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=50>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.a — Introduction** · page 50 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.b.i — The physician should assess/re-assess risks and benefits of the patient’s {#f.3.b.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.b.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=50>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.b.i — The physician should assess/re-assess risks and benefits of the patient’s** · pages 50–51 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.b.ii — If there is evidence of significant adverse effects from opioid therapy, the physician should reduce the opioid dose and reassess the patient’s status. {#f.3.b.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.b.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=51>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.b.ii — If there is evidence of significant adverse effects from opioid therapy, the physician should reduce the opioid dose and reassess the patient’s status.** · pages 51–52 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.b.iii — If there are no indications for dose reduction or discontinuation of opioids, and the patient demonstrates benefit from the opioid {#f.3.b.iii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.b.iii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=52>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.b.iii — If there are no indications for dose reduction or discontinuation of opioids, and the patient demonstrates benefit from the opioid** · page 52 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.b.iv — The patient should not engage in safety-sensitive activities, or activities that could cause risk to individual, workplace or public {#f.3.b.iv}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.b.iv*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=52>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.b.iv — The patient should not engage in safety-sensitive activities, or activities that could cause risk to individual, workplace or public** · page 52 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.c — Patient Informed Consent for Opioid Treatment Form and Patient {#f.3.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=52>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.c — Patient Informed Consent for Opioid Treatment Form and Patient** · page 52 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.c.i — Patient Informed Consent for Opioid Treatment Form (Appendix F) {#f.3.c.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.c.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=52>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.c.i — Patient Informed Consent for Opioid Treatment Form (Appendix F)** · pages 52–53 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.c.ii — Patient Understanding for Opioid Treatment Form (Appendix G) {#f.3.c.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.c.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=53>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.c.ii — Patient Understanding for Opioid Treatment Form (Appendix G)** · page 53 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.d.i — UDT Introduction {#f.3.d.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.d.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=53>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.d.i — UDT Introduction** · pages 53–55 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.d.ii — Confidentiality and Reporting UDT Results {#f.3.d.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.d.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=55>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.d.ii — Confidentiality and Reporting UDT Results** · pages 55–56 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.d.iii — Methods of Urine Drug Testing {#f.3.d.iii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.d.iii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=56>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.d.iii — Methods of Urine Drug Testing** · pages 56–57 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.d.iv — Interpreting Results {#f.3.d.iv}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.d.iv*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=57>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.d.iv — Interpreting Results** · pages 57–58 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.e — Optimizing Opioid Doses {#f.3.e}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.e*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=59>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.e — Optimizing Opioid Doses** · page 59 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.e.i — Equianalgesic Doses (ED) {#f.3.e.i}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.e.i*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=59>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.e.i — Equianalgesic Doses (ED)** · pages 59–61 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.e.ii — Opioid Doses greater than or equal to 100mg/MED {#f.3.e.ii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.e.ii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=61>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.e.ii — Opioid Doses greater than or equal to 100mg/MED** · pages 61–63 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.e.iii — Reasons to Discontinue Opioids and/or Refer to a Physician specializing {#f.3.e.iii}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.e.iii*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=63>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.e.iii — Reasons to Discontinue Opioids and/or Refer to a Physician specializing** · pages 63–64 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.e.iv — General Guidelines for Opioid Tapering/Discontinuation {#f.3.e.iv}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.e.iv*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=64>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.e.iv — General Guidelines for Opioid Tapering/Discontinuation** · pages 64–65 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.e.v — Recognizing and Managing Behavioral Issues during Opioid {#f.3.e.v}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.e.v*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=65>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.e.v — Recognizing and Managing Behavioral Issues during Opioid** · page 65 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.3.e.vi — Specialty Consultations (See Table 8: Guidance for Seeking Consultative Assistance) {#f.3.e.vi}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.3.e.vi*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=65>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.3.e.vi — Specialty Consultations (See Table 8: Guidance for Seeking Consultative Assistance)** · pages 65–66 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.4 — Opioid-Related Medications: Tramadol, Methadone, {#f.4}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.4*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=66>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.4 — Opioid-Related Medications: Tramadol, Methadone,** · page 66 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.4.a — Tramadol {#f.4.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.4.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=66>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.4.a — Tramadol** · pages 66–67 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.4.b — Methadone {#f.4.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.4.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=67>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.4.b — Methadone** · page 67 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.4.c — Buprenorphine {#f.4.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.4.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=67>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.4.c — Buprenorphine** · pages 67–68 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § F.4.d — Tapentadol {#f.4.d}

*NY WCB Non-Acute Pain MTG, 2d ed., § F.4.d*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=68>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ F.4.d — Tapentadol** · page 68 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § G.1 — Implantable Spinal Cord Stimulator (SCS) {#g.1}

*NY WCB Non-Acute Pain MTG, 2d ed., § G.1*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=68>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ G.1 — Implantable Spinal Cord Stimulator (SCS)** · page 68 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § G.1.a — Indications {#g.1.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § G.1.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=69>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ G.1.a — Indications** · pages 69–70 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § G.1.b — SCS Neurostimulation Screening Trial {#g.1.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § G.1.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=70>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ G.1.b — SCS Neurostimulation Screening Trial** · pages 70–71 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § G.1.c — Permanent SCS Implantation {#g.1.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § G.1.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=71>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ G.1.c — Permanent SCS Implantation** · page 71 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § G.2 — Peripheral Nerve Stimulation (PNS) {#g.2}

*NY WCB Non-Acute Pain MTG, 2d ed., § G.2*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=71>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ G.2 — Peripheral Nerve Stimulation (PNS)** · pages 71–72 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § G.3 — Intrathecal Drug Delivery (Pain Pumps) {#g.3}

*NY WCB Non-Acute Pain MTG, 2d ed., § G.3*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=72>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ G.3 — Intrathecal Drug Delivery (Pain Pumps)** · page 72 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § G.3.a — Indications {#g.3.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § G.3.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=72>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ G.3.a — Indications** · pages 72–73 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § G.3.b — Pain Pump Screening Trial {#g.3.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § G.3.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=73>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ G.3.b — Pain Pump Screening Trial** · page 73 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § G.3.c — Pain Pump Implantation {#g.3.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § G.3.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=73>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ G.3.c — Pain Pump Implantation** · pages 73–74 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § H.1.a — Ongoing, Independent, Self-Management Plan {#h.1.a}

*NY WCB Non-Acute Pain MTG, 2d ed., § H.1.a*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=74>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ H.1.a — Ongoing, Independent, Self-Management Plan** · page 74 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § H.1.b — Self-Directed Pain Management Plan {#h.1.b}

*NY WCB Non-Acute Pain MTG, 2d ed., § H.1.b*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=74>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ H.1.b — Self-Directed Pain Management Plan** · page 74 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § H.1.c — Review of Self-Management and Self-Directed Treatment Programs {#h.1.c}

*NY WCB Non-Acute Pain MTG, 2d ed., § H.1.c*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=74>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ H.1.c — Review of Self-Management and Self-Directed Treatment Programs** · pages 74–75 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § H.1.d — Ongoing Care {#h.1.d}

*NY WCB Non-Acute Pain MTG, 2d ed., § H.1.d*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=75>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ H.1.d — Ongoing Care** · page 75 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

---

## Non-Acute Pain MTG § H.1.e — Ongoing Maintenance Care {#h.1.e}

*NY WCB Non-Acute Pain MTG, 2d ed., § H.1.e*

Official source: <https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Non-AcutePainMTG2021.pdf#page=75>

_NY WCB Non-Acute Pain Medical Treatment Guidelines, Second Edition (March 25, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(6)._

**§ H.1.e — Ongoing Maintenance Care** · pages 75–76 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).
